Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 12—December 2025
Dispatch
Case of Congenital Tularemia with Neuroinvasive Disease, Utah, USA
Table 2
Infant and maternal testing for Francisella tularensis in study of congenital tularemia with neuroinvasive disease, Utah, USA*
| Test, specimen source | Infant | Mother |
|---|---|---|
| Microbial cell free DNA metagenomic sequencing (Karius), plasma† | 4 weeks: 804 MPM F. tularensis subsp. holartica cfDNA (Appendix) | NA |
| 7 weeks: 11 MPM F. tularensis subsp. holartica cfDNA (Appendix) |
||
| F. tularensis IgM, serum | 4 weeks: negative | 6 weeks postpartum: positive |
| 8 weeks: negative |
||
| F. tularensis IgG, serum | 4 weeks: positive | 6 weeks postpartum: positive |
| 8 weeks: negative |
||
| Culture data | (Table 1) | Neck abscess (35 weeks’ gestation): no growth × 5 d |
| Throat culture (6 weeks postpartum): no growth × 5 d |
||
| Next-generation metagenomic sequencing, CSF‡ |
4 weeks: negative |
NA |
| Multiplex PCR panel (BioFire), serum |
4 weeks: negative |
NA |
| Multiplex PCR panel, (BioFire); meningitis/encephalitis panel (Filmarray), CSF |
4 weeks: negative |
NA |
| Francisella tularensis immunohistochemistry, FFPE maternal fallopian tube tissue§ |
NA |
Francisella spp. antigens detected (Figure 2) |
| Gram-negative bacteria 16S rRNA gene PCR test, FFPE maternal fallopian tube tissue§ | NA | Positive for Francisella spp. |
*cfDNA, cell-free DNA; CSF, cerebrospinal fluid; FFPE, formalin-fixed paraffin-embedded; MPM, molecules per microliter; NA, not applicable. †Testing performed at Karius (https://kariusdx.com). ‡Testing performed at University of California, San Francisco (San Francisco, CA, USA). §Testing performed at Centers for Disease Control and Prevention (Atlanta, GA, USA).
Page created: November 18, 2025
Page updated: December 12, 2025
Page reviewed: December 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.